Vivo Capital as of June 30, 2017
Portfolio Holdings for Vivo Capital
Vivo Capital holds 26 positions in its portfolio as reported in the June 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Aclaris Therapeutics (ACRS) | 19.5 | $78M | 2.9M | 27.12 | |
| Biohaven Pharmaceutical Holding Company | 12.4 | $49M | 2.0M | 25.00 | |
| Ascendis Pharma A S (ASND) | 12.3 | $49M | 1.8M | 27.76 | |
| Nabriva Therapeutics | 10.6 | $42M | 4.0M | 10.48 | |
| Codexis (CDXS) | 7.3 | $29M | 5.3M | 5.45 | |
| Selecta Biosciences (RNAC) | 5.6 | $22M | 1.1M | 19.86 | |
| Strongbridge Bioph shs usd | 5.4 | $22M | 3.0M | 7.15 | |
| Aimmune Therapeutics | 4.0 | $16M | 777k | 20.56 | |
| Eiger Biopharmaceuticals | 3.6 | $14M | 1.8M | 7.90 | |
| Advanced Accelerat spon ads each rep 2 ord | 3.5 | $14M | 359k | 39.04 | |
| Verona Pharma Plc ads (VRNA) | 2.1 | $8.2M | 704k | 11.66 | |
| Capnia | 1.9 | $7.3M | 15M | 0.50 | |
| Biopharmx | 1.7 | $6.8M | 14M | 0.48 | |
| Aurinia Pharmaceuticals (AUPH) | 1.6 | $6.2M | 1.0M | 6.13 | |
| Agile Therapeutics | 1.4 | $5.7M | 1.5M | 3.75 | |
| Trevena | 1.0 | $4.0M | 1.7M | 2.30 | |
| Foamix Pharmaceuticals | 1.0 | $4.0M | 855k | 4.64 | |
| Dynavax Technologies (DVAX) | 0.9 | $3.5M | 360k | 9.65 | |
| Regenxbio Inc equity us cm (RGNX) | 0.8 | $3.2M | 164k | 19.75 | |
| Pronai Therapeutics | 0.7 | $2.9M | 2.4M | 1.17 | |
| Akari Therapeutics | 0.6 | $2.4M | 528k | 4.61 | |
| Crispr Therapeutics (CRSP) | 0.6 | $2.4M | 149k | 16.02 | |
| Kalvista Pharmaceuticals | 0.6 | $2.2M | 300k | 7.36 | |
| Revance Therapeutics (RVNC) | 0.5 | $2.0M | 77k | 26.40 | |
| Sunesis Pharmaceuticals Inc Ne | 0.3 | $1.4M | 500k | 2.70 | |
| Capnia Inc Common Stock Warrants | 0.0 | $161k | 944k | 0.17 |
